generated: '2026-08-26'
method: searched
source: https://www.precisedx.ai/billing-program
plan_count: 0
note: >-
  PreciseDx publishes no plans, tiers, or list pricing of any kind — not for an API
  (it has none) and not for its diagnostic test. PreciseBreast is a CLIA laboratory
  developed test ordered by a clinician through an authenticated portal and billed to
  the patient's health plan, so the commercial surface is payor reimbursement plus a
  patient billing program and a patient assistance program, not a published price
  list. The company's own marketing states PreciseBreast costs roughly 30 percent of
  gene expression testing, but no dollar figure, tier, quota, or overage is published
  anywhere on the site. This file records a measured absence; NO Plans pointer is
  wired into apis.yml, because a pointer would assert a published plan surface the
  company does not serve.
plans: []
evidence:
- url: https://www.precisedx.ai/billing-program
  status: 200
  finding: patient billing program, insurance/payor billing guidance, no price list
- url: https://www.precisedx.ai/patient-assistance-program
  status: 200
  finding: financial assistance program for patients, no published pricing
- url: https://www.precisedx.ai/payors
  status: 200
  finding: payor-facing reimbursement page, no published rates